UNSPSC 51271633: Prilocaine hydrochloride

This classification denotes an anesthetic agent with the molecular formula C13H20N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MJW015BAPH, chemically known as propanamide, n-(2-methylphenyl)-2-(propylamino)-, monohydrochloride but more generally known as prilocaine hydrochloride, which bears US NIH Compound Identifier 92163. European Medicines Agency schedules Prilocaine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04038MIG.

Most nations, for tariff and trade purposes, schedule prilocaine hydrochloride under HS 29242995 and SITC 51479. As of Q4 2014, PRILOCAINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Prilocaine hydrochloride bears US NLM identifiers UMLS ID C0591261 and NCI Concept Code C48012. SMILES: CCCNC(C)C(=O)NC1CCCCC1C.CL.

UNSPSC 51271633 Prilocaine hydrochloride is a Commodity code for a local anesthetic pharmaceutical used in state and local health care and emergency medical settings. State and local procurement under this code consists of direct pharmaceutical purchases for injection or topical application, typically ordered through standing supply agreements or routine RFQs by health departments, correctional facilities, emergency medical services, and hospital systems. The work is straightforward commodity procurement — agencies specify quantity, formulation (typically injectable solution at standard concentrations), delivery schedule, and pricing, with vendors responding through sealed bids or price quotes.

The source provides no recent state and local contract opportunities under this code. Without posted solicitations, geographic concentration and issuing-body mix cannot be characterized from current activity. Prilocaine hydrochloride procurement at the state and local level is typically routine pharmaceutical supply business conducted through established GPOs, state health department contracts, or cooperative purchasing vehicles rather than competitive solicitations posted in public notice channels. Firms pursuing sales under this code should track standing supply agreements with state health departments, county correctional systems, and municipal EMS agencies rather than expect frequent open-market RFQs.